Hsiang-Lin Lee

Hsiang-Lin Lee

Auto-generated profile, based on publicly available information

Hsiang-Lin Lee

School of Medicine, Chung Shan Medical University, Taichung, Taiwan, csmu.edu.tw

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2025 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
KCKai Lun Cheng
Kai Lun Cheng
WYWei-Shin Yu
Wei-Shin Yu
YWYu-Hsun Wang
Yu-Hsun Wang
GHGema Hernandez-Ibarburu
Gema Hernandez-Ibarburu
HLHsiang-Lin Lee
Hsiang-Lin Lee
CHENGCHUNG WEICHENGCHUNG WEI
CHENGCHUNG WEI
Context: Reports on long-term thyroid dysfunction following COVID-19 vaccination are limited. Understanding the risk of subacute thyroiditis, hyperthyroidism, and hypothyroidism in vaccinated individuals is crucial for postvaccination monitoring. Objective: This study evaluated the risk of thyroid dysfunction in individuals vaccinated against COVID-19 compared to unvaccinated individuals, using a large cohort. Methods: We conducted a retrospective cohort study from January 1, 2022, to December 31, 2023, using the TriNetX database, including 1 166 748 vaccinated and 1 166 748 unvaccinated individuals. Propensity score matching was used to balance baseline characteristics. The primary outcomes were new diagnoses of subacute thyroiditis, hyperthyroidism, and hypothyroidism. Results: The risk of subacute thyroiditis remained unchanged (95% CIs included 1). A significant reduction in hyperthyroidism risk was observed from 3 to 9 months postvaccination (hazard ratios [HRs]: 0.65-0.89, all 95% CIs below 1), but this trend was not significant at 12 months (HR: 0.99; 95% CI: 0.92-1.06). In contrast, the risk of hypothyroidism significantly increased from 6 to 12 months postvaccination (HR: 1.14-1.30, all 95% CIs above 1). Among mRNA vaccine recipients, the risk of both hyperthyroidism and hypothyroidism was significantly elevated at 12 months (HR: 1.16-2.13). Conclusion: COVID-19 vaccination was associated with a reduced risk of hyperthyroidism and an increased risk of hypothyroidism, highlighting the need for ongoing thyroid function monitoring.

1 January 2026 in Case Reports in Endocrinology
Verified
Journal Article
Open access
MYMei-Chen Yeh
Mei-Chen Yeh
WYWei-Shin Yu
Wei-Shin Yu
HLHsiang-Lin Lee
Hsiang-Lin Lee
YLYu-Shen Lee
Yu-Shen Lee
KCKai Lun Cheng
Kai Lun Cheng
Voice change is a recognized complication of radiofrequency ablation (RFA) for thyroid nodules, primarily resulting from thermal injury to the recurrent laryngeal nerve or adjacent structures. Although most cases resolve spontaneously over several weeks to months, timely intervention may help reduce patient discomfort and anxiety. This retrospective case series examined five patients who developed voice changes during or immediately after RFA for benign thyroid nodules and were managed with direct ice packing. Ipsilateral vocal cord (VC) hypomobility was confirmed via real‐time laryngeal ultrasound, followed by immediate application of ice to the skin overlying the thyroid. VC movement and skin integrity were assessed every 10 min. All patients achieved complete symptom resolution within 20–50 min (median: 30 min) without complications. No cold‐induced skin injury occurred, and no additional treatment was required. While spontaneous recovery cannot be excluded, the relatively rapid improvement observed in this series suggests that direct ice packing may represent a safe, practical, and noninvasive management option for RFA‐related voice changes. Further studies are warranted to confirm its efficacy in larger and more diverse populations.